Nike, Inc. (NKE) Stock Analysis

HOLD

NKE Equity Research — HOLD — June 2026

Rating date

Jun 18, 2026

53 days ago

Desk view

HOLD

5D move

Neutral (HOLD unscored)

Peer rank

45p

Investment card · NKE

Here is the analysis for NKE (Nike, Inc.) as of June 18, 2026.

Desk rating

HOLD

Tactical HOLD · 12M HOLD

Horizon

Short to medium term

Confidence

Low

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

HOLD

Catalysts

  • Deeply bearish on the long-term time frame. The price is ~24% below the 200-day SMA, and the 50-day/200-day relationship is firmly negative — a classic death-cross setup with no reversal signal yet.
  • Short-term momentum has turned mildly positive. The MACD crossing above zero in early June is the most constructive technical signal currently available, but it is very early and showing signs of stalling.
  • Price is consolidating at a potential support zone. The $42–$44 range has held since mid-May, and the 50-day SMA has flattened, suggesting sellers are exhausting. A break below $42 would be a bearish deterioration; a move above $47 (Bollinger upper band) would suggest a stronger recovery.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

NKE Research Note

Full desk note for Jun 18, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

31 min read

WebserviceX · Agentic Research Desk

NKE Equity Research Note

Published Jun 18, 2026 · Desk view HOLD · Generated 2026-06-19T08:18:42Z · Maintained by Walter Vijayakumar · Methodology · Track record

NKE Stock Rating Summary

NKE bias

HOLD

Horizon

Short to medium term

NKE key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

NKE catalyst watch

Deeply bearish on the long-term time frame. The price is ~24% below the 200-day SMA, and the 50-day/200-day relationship is firmly negative — a classic death-cross setup with no reversal signal yet.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Low

How the call aged · 5D

Neutral (HOLD unscored)Peer 45p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-19T08:42:40.324246+00:00.

5D move

2026-06-17 → awaiting

Outcome

Neutral (HOLD unscored)

5D trend

+0.52%

Vol (20D ann.)

+36.51%

vs SPY: -1.62%

Close 44.19 (USD, vendor closes)

Batch scorecard · 2026-06-18 · NKE

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace ae089f97

No QC issues recorded.